Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
Dec 19 2024
Length: 26 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Listen for free

View show details

Summary
Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL Recorded on November 21, 2024 Celeste Bello, MD Senior Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!

Show more Show less

Limited time offer. Just $0.99 a month for the first 3 months. Get this deal.

Show more Show less

What listeners say about Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon